hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06317701 id: IRB23-1801 briefTitle: Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation overallStatus: RECRUITING date: 2024-04-04 date: 2028-04 date: 2028-04 date: 2024-03-19 date: 2024-04-09 name: University of Chicago class: OTHER briefSummary: The purpose of this study is to determine if the treatment of Obstructive sleep apnea (OSA) by hypoglossal nerve stimulation (HGNS) will alter glucose metabolism. The study team will also determine if the treatment of Obstructive sleep apnea (OSA) by (hypoglossal nerve stimulation) HGNS will alter predictors of cardiovascular outcomes. conditions: Obstructive Sleep Apnea studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 30 type: ESTIMATED name: Hypoglossal Nerve Stimulation (HGNS) measure: Glycemic variability measure: Mean systolic BP (daytime and nocturnal) measure: Glycemic variability measure: mean blood glucose levels measure: mean ambulatory glucose excursions measure: time blocks measure: Morning fasting insulin, including calculated insulin resistance (HOMA-IR) measure: Mean norepinephrine levels measure: Morning fasting blood glucose measure: Hemoglobin A1c measure: Insulin levels measure: c-peptide levels measure: fasting lipid profile (triglycerides) measure: heart rate indices by activity monitor measure: sympathetic activity by plasma norepinephrine measure: Morning fasting insulin of c-peptide level measure: fasting lipid profile (HDL- cholesterol) measure: fasting lipid profile ( LDL-cholesterol) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The University of Chicago status: RECRUITING city: Chicago state: Illinois zip: 60637 country: United States name: Phillip LoSavio, MD, MS role: CONTACT phone: 773-702-5189 email: Phillip.Losavio@bsd.uchicago.edu name: Leila Yazdanbakhsh role: CONTACT phone: 773-834-5087 email: leila.yazdanbakhsh@bsd.uchicago.edu name: Phillip LoSavio, MD, MS role: PRINCIPAL_INVESTIGATOR lat: 41.85003 lon: -87.65005 hasResults: False
nctId: NCT06317688 id: TWU IRB-FY2023-157 briefTitle: Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis overallStatus: ENROLLING_BY_INVITATION date: 2023-11-06 date: 2024-08-14 date: 2024-08-14 date: 2024-03-19 date: 2024-03-27 name: Texas Woman's University class: OTHER name: Harris Health System (Houston, Texas) briefSummary: Problem of the Study This study was designed to test the effectiveness of the application of extra-virgin coconut oil versus Highly Purified Anhydrous (HPA) Lanolin in ameliorating nipple pain, cracking and eventually the prevention of subacute lactation mastitis in breastfeeding women. It is theorized that the nipple crack, nipple pain are early warning signs of subacute clinical lactation mastitis. Goal is after application of extra-virgin coconut oil comparative analysis will be done at one week, three weeks, and six weeks. These complications associated with development of subacute mastitis can be addressed early during the first six weeks of lactation. conditions: Lactation Mastitis conditions: Breast Feeding conditions: Staphylococcus Aureus Infection studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized Control Trial- Random Assignment-Random Selection primaryPurpose: TREATMENT masking: NONE count: 100 type: ESTIMATED name: Extra-Virgin Coconut Oil measure: Measurement of change in pain level (Numeric Pain Rating Scale McCaffery, 1989) measure: Measurement of Development of Nipple Crack (Nipple Tenderness Scale Storr 1988) sex: FEMALE minimumAge: 18 Years maximumAge: 45 Years stdAges: ADULT facility: Harris Health System city: Houston state: Texas zip: 77030 country: United States lat: 29.76328 lon: -95.36327 hasResults: False
nctId: NCT06317675 id: ct9873 briefTitle: Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease overallStatus: RECRUITING date: 2024-02-18 date: 2025-12 date: 2026-04 date: 2024-03-19 date: 2024-03-25 name: Studio Osteopatico Busto Arsizio class: OTHER briefSummary: To evaluate the effects of osteopathic manipulative treatment in patients affected by symptoms related to gastro-oesophageal reflux disease (GERD) conditions: Gastro-oesophageal Reflux Disease studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: Osteopathic manipulative treatment (OMT) measure: Mean change in GERD-HRQL measure: Adverse effects measure: Exercise adherence measure: Change in drugs use sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: CTFO status: RECRUITING city: Saronno state: Varese zip: 21047 country: Italy name: +39 02 96701013 role: CONTACT lat: 45.62513 lon: 9.03517 hasResults: False
nctId: NCT06317649 id: NCI-2024-01987 id: NCI-2024-01987 type: REGISTRY domain: CTRP (Clinical Trial Reporting Program) id: MM1OA-EA02 type: OTHER domain: ECOG-ACRIN Cancer Research Group id: MM1OA-EA02 type: OTHER domain: CTEP id: U10CA180820 type: NIH link: https://reporter.nih.gov/quickSearch/U10CA180820 briefTitle: Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial) overallStatus: NOT_YET_RECRUITING date: 2024-05-30 date: 2025-10-31 date: 2025-10-31 date: 2024-03-19 date: 2024-03-19 name: National Cancer Institute (NCI) class: NIH briefSummary: This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach. conditions: Acute Myeloid Leukemia studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 147 type: ESTIMATED name: Azacitidine name: Biospecimen Collection name: Bone Marrow Aspiration name: Bone Marrow Biopsy name: Gilteritinib name: Venetoclax measure: Rate of measured residual disease (MRD) negative complete remission (CR) measure: Overall survival measure: Event-free survival measure: Incidence of adverse events sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06317636 id: 73487 briefTitle: Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression acronym: PEAK overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2025-01 date: 2025-05 date: 2024-03-19 date: 2024-04-11 name: Stanford University class: OTHER briefSummary: The goal of this clinical trial is to compare ketamine to a placebo when given as a single infusion during sedation in adults with chronic pain and depression. This study aims to:
* Complete several study assessments over 5-7 weeks conditions: Chronic Pain conditions: Depression studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 32 type: ESTIMATED name: Ketamine name: Normal saline measure: Pain Intensity (past 24 hours) measure: Depression severity measure: Pain Intensity (current) measure: Number and severity of adverse events related to sedation measure: Proportion of participants who accurately recall intra-sedation events measure: Treatment guess measure: Treatment expectancies measure: Pain interference measure: Physical function measure: Number of painful body regions measure: Change in pain medication utilization measure: Pressure pain threshold measure: Enrollment rate measure: Consent fraction measure: Participant Experience Survey sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06317623 id: 0292/21/2023-00590 briefTitle: Urinary Tract Dilations in Prenatal and Postnatal Life overallStatus: RECRUITING date: 2023-01-01 date: 2025-12 date: 2026-06 date: 2024-03-19 date: 2024-03-19 name: SonoClinic class: NETWORK briefSummary: The goals of this study are to use a questionnaire survey to determine the state of awareness of the diagnosis and management of patients with urinary tract dilation across several medical professionals, to predict the severity of the postnatal course and surgical intervention in fetuses with urinary tract dilation detected during pregnancy, and to create a model of prenatal and postnatal care for patients with dilation of the urinary tract for multidisciplinary use. conditions: Urinary Tract Dilatation studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 200 type: ESTIMATED name: Prenatal and postnatal ultrasound examination measure: The goal is the prediction of severe postnatal course and surgical intervention in fetuses with dilatation of the urinary tract according to the UTD classification created in 2014. sex: FEMALE minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Svetlana Jánošová status: RECRUITING city: Záborské zip: 08253 country: Slovakia name: Svetlana Jánošová role: CONTACT phone: +421908369470 email: svetlana.janosova@gmail.com name: Róbert Dankovčík role: CONTACT phone: +4219051291297 email: dankovcik@gmail.com lat: 48.9451 lon: 21.28977 typeAbbrev: Prot hasProtocol: True hasSap: False hasIcf: False label: Study Protocol date: 2023-12-19 uploadDate: 2024-02-26T14:43 filename: Prot_000.pdf size: 1211102 typeAbbrev: ICF hasProtocol: False hasSap: False hasIcf: True label: Informed Consent Form date: 2023-12-19 uploadDate: 2024-02-26T14:43 filename: ICF_001.pdf size: 373557 hasResults: False
nctId: NCT06317610 id: CQGOG0206 briefTitle: Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids overallStatus: RECRUITING date: 2022-01-01 date: 2024-04-30 date: 2024-05-30 date: 2024-03-19 date: 2024-03-19 name: Chongqing University Cancer Hospital class: OTHER briefSummary: The present study aims to collect early bright field image of patient-derived organoids with ovarian cancer. By leveraging artificial intelligence, this study will seek to construct and refine algorithms that able to predict growth of ovarian cancer organoids. conditions: Ovarian Cancer studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: OTHER count: 100 type: ESTIMATED name: growth prediction of ovarian cancer organoids in the frame of bright field image by leveraging AI measure: AUC of growth prediction performance using deep learning model measure: Accuracy of growth prediction using deep learning model sex: FEMALE stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Chongqing Cancer Hospital status: RECRUITING city: Chongqing state: Chongqing zip: 400030 country: China name: Dongling Zou, M.D. role: CONTACT phone: 13657690699 email: cqzl_zdl@163.com name: Dongling Zou, M.D. role: PRINCIPAL_INVESTIGATOR lat: 29.56278 lon: 106.55278 hasResults: False
nctId: NCT06317597 id: OSS2024-0311 briefTitle: Efficacy of Short Time Intervals in Split-Dose Bowel Preparation of Oral Sulfate Solution for Colonoscopy overallStatus: ENROLLING_BY_INVITATION date: 2024-03-15 date: 2024-12-01 date: 2024-12-30 date: 2024-03-19 date: 2024-03-19 name: Changhai Hospital class: OTHER name: Peking University People's Hospital name: Internet Hospital of Tianjin Medical University General Hospital name: The Affiliated Suzhou Hospital of Nanjing Medical University name: Tianjin First Central Hospital name: Tianjin Beichen Hospital name: ShangDong Provincial Hospital name: The Affiliated Hospital of Qingdao University name: First People's Hospital of Hangzhou name: The Third People's Hospital of Chengdu name: Ningbo Yinzhou District Second Hospital name: Changshu Affiliated Hospital of Soochow University name: Linyi People's Hospital name: Shanghai East Hospital name: Heilongjiang Province Hospital Nangang Branch name: The Affiliated Jiangyin Hospital of Nantong University name: West China Hospital briefSummary: To evaluate whether oral sulfate solution administered in a short time interval (6-8 hours) between the first and last dose of laxative is not inferior to a long time interval (10-12 hours) in bowel preparation quality. conditions: Colonoscopy: Bowel Preparation studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: DIAGNOSTIC masking: TRIPLE whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 448 type: ESTIMATED name: Magnesium Sulfate，Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution name: Magnesium Sulfate，Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution measure: Bowel preparation adequate rate measure: Acceptability of bowel preparation by questionnaire survey measure: Incidence of laxative-related adverse events assessed by clinical examinations measure: Colonoscopy completion rate sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Changhai Hospital city: Shanghai country: China lat: 31.22222 lon: 121.45806 hasResults: False
nctId: NCT06317584 id: NMRPF3M0042 briefTitle: Empowerment-based Complementary and Alternative Medicine (ECAM) acronym: CAM overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-03-04 date: 2025-07-31 date: 2024-03-19 date: 2024-03-21 name: Chang Gung University of Science and Technology class: OTHER name: National Science and Technology Council name: Chang Gung Memorial Hospital briefSummary: This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes. conditions: Diabetes studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized trail method primaryPurpose: HEALTH_SERVICES_RESEARCH masking: QUADRUPLE maskingDescription: The process of keeping the study group assignment hidden after the allocation to participant, care provider, investigator, outcomes assessor whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 86 type: ESTIMATED name: Experimental: Empowerment Application for CAM Health Education name: Written Paper for CAM Health Education measure: Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire measure: Quality of life questionnaire measure: Diabetes Empowerment scale measure: Blood Glucose (GLU) measure: Glycated Hemoglobin(HbA1c) measure: ALanine aminoTransferase，Glutamic Pyruvic Transaminase(ALT/GPT) measure: ASpartate aminoTransferase，Glutamic Oxaloacetic Transaminase (AST/GOT) measure: Blood Urea Nitrogen(BUN) measure: Creatinine(CREA) measure: High Density Lipoprotein(HDL) measure: Total Bilirubin(T.BIL) measure: Serum total cholesterol(TC) measure: Triglyceride (TG) measure: Glomerular filtration rate(GFR) measure: Albumin to Creatinine Ratio (ACR) sex: ALL minimumAge: 20 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT facility: CHENG GUNG MEMORIAL HOSPITAL, Linkou city: Taoyuan City state: Guishan District zip: 333 country: Taiwan lat: 24.95233 lon: 121.20193 hasResults: False
nctId: NCT06317571 id: CelalBayarU-SBF-OT-01 briefTitle: Evaluation of The Effect of Fertility Support Education Given to Infertile Couples overallStatus: COMPLETED date: 2021-03-15 date: 2021-12-28 date: 2022-08-10 date: 2024-03-19 date: 2024-03-20 name: Celal Bayar University class: OTHER briefSummary: The aim of the this study was to evaluate the effect of fertility support education given to infertile couples before treatment. conditions: Infertility studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Two groups with intervention group and control group primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 90 type: ACTUAL name: fertility support education measure: Infertility Stress Scale measure: Infertility Self-Efficacy Scale-Short Form measure: Fertility Readiness Scale measure: Fertiqol Quality of Life Scale measure: Blood cortisol level sex: ALL minimumAge: 18 Years maximumAge: 45 Years stdAges: ADULT facility: Manisa Celal Bayar Üniversitesi Hafsa Sultan Hastanesi city: Manisa zip: 45060 country: Turkey lat: 38.61202 lon: 27.42647 hasResults: False
nctId: NCT06317558 id: 22/492-3694 briefTitle: Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy acronym: NeoIM-Lung overallStatus: RECRUITING date: 2024-03-01 date: 2026-03-01 date: 2027-12-31 date: 2024-03-19 date: 2024-03-19 name: Cancer Institute and Hospital, Chinese Academy of Medical Sciences class: OTHER briefSummary: The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of different neoadjuvant immunotherapies in NSCLC patients using the real-world data. The main questions it aims to answer are:
* How to determine the subgroups of patients benefit from neoadjuvant immunotherapy? Participants will receive neoadjuvant immunotherapy the study will analyze the real-world data. conditions: NSCLC studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 4000 type: ESTIMATED name: Neoadjuvant immunotherapy name: Other drugs for neoadjuvant treatment measure: Pathological Complete Response (pCR) measure: Disease-free survival(DFS) measure: OS (overall survival) measure: EFS (event-free survival) measure: Major Pathological Response (MPR) measure: Relapse Patterns sex: ALL minimumAge: 18 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Shugeng Gao status: RECRUITING city: Beijing state: Beijing zip: 100020 country: China name: Shugeng Gao, Vice president role: CONTACT phone: 010-87788177 email: gaoshugeng@cicams.ac.cn lat: 39.9075 lon: 116.39723 hasResults: False
nctId: NCT06317545 id: REC/RCR&AH/23/0167/shan ali briefTitle: Effects of Nerchal Exercises on Lateral Epicondylitis. overallStatus: COMPLETED date: 2023-11-01 date: 2024-03-28 date: 2024-03-28 date: 2024-03-19 date: 2024-04-19 name: Riphah International University class: OTHER briefSummary: Painful condition of lateral epicondyle of the humerus characterized by the inflammation of the tendons during loading of the wrist extensor muscles is a common musculoskeletal presentation in men and women between 35 and 54 years of age. The above symptom is associated with a clinical diagnosis of lateral elbow tendinopathy (LET), also known as tennis elbow or lateral epicondylalgia the two effective treatment approaches for lateral epicondylitis are Nirschl exercises and Mulligan taping. This study aims to evaluate the effectiveness of Nirschl exercises with or without Mulligan taping in treating lateral epicondylitis. The study design for this project employs a randomized controlled trial and a sample of individuals with lateral epicondylitis randomly assigned in one of the two groups i.e., Nirschl exercises only and Nirschl exercises with Mulligan taping. Nirschl exercises involve the eccentric strengthening of the wrist extensor muscles and forearm. The participants in both groups will receive Nirschl exercises while the second group will also receive Mulligan taping, which involves the application of tape to the lateral aspect of the elbow to offload stress during movement of the extensor tendons. Different outcome measures including pain intensity, functional disability, grip strength, range of motion will be evaluated using, PRTEE Scale, Visual Analogue Scale (VAS) and Calibrated Jammer hand held dynamometer. Statistical analysis, including independent t-tests or chi-square tests, will be conducted to compare the outcomes between the two groups. The significance level will be set at p \< 0.05. This study will contribute to the evidence base regarding the efficacy of Nirschl exercises and Mulligan taping in managing lateral epicondylitis and will help the clinicians and patients in deciding the best treatment approach for lateral epicondylitis. conditions: Lateral Epicondylitis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 56 type: ACTUAL name: Mulligan Taping measure: Pain intensity measure: Grip strength measure: Disability sex: ALL minimumAge: 18 Years maximumAge: 45 Years stdAges: ADULT facility: BARKI Advanced Physiotherapy Center city: Multan state: Punjab zip: 60000 country: Pakistan lat: 30.19679 lon: 71.47824 facility: KAIMS Physiotherapy and Rehabilitation Center city: Multan state: Punjab zip: 60000 country: Pakistan lat: 30.19679 lon: 71.47824 hasResults: False
nctId: NCT06317532 id: P.T.REC/012/004766 briefTitle: Effect of Functional Exercises on Pain and Quality of Life in Females With Primary Dysmenorrhea overallStatus: NOT_YET_RECRUITING date: 2024-03-20 date: 2024-05-20 date: 2024-05-20 date: 2024-03-19 date: 2024-03-20 name: Cairo University class: OTHER briefSummary: The aim of the study will be to investigate the effect of functional exercises on pain and quality of life in females with primary dysmenorrhea. conditions: Primary Dysmenorrhea studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 58 type: ESTIMATED name: Lifestyle modification advice name: Functional exercises measure: Visual analogue scale (VAS) measure: The Menstrual Distress Questionnaire measure: Quality of life enjoyment and satisfaction questionnaire measure: Pressure pain threshold assessment sex: FEMALE minimumAge: 18 Years maximumAge: 25 Years stdAges: ADULT facility: Cairo University city: Giza country: Egypt name: Manar E. Al-Emary, M.Sc. Stud role: CONTACT phone: +20 128 660 0931 email: manaralemary@gmail.com name: Mai Mohamed Ali, PhD role: CONTACT name: Soheir Mahmoud Elkosery, Prof. role: PRINCIPAL_INVESTIGATOR name: Amr Hazem Abbassy, Assis. Prof. role: PRINCIPAL_INVESTIGATOR lat: 30.00808 lon: 31.21093 hasResults: False
nctId: NCT06317519 id: 09.2020-Oss briefTitle: Verify the Performance in Clinical Practice of the Immersive Virtual Reality Platform GRAIL (Gait Real-time Analysis Interactive Lab) overallStatus: RECRUITING date: 2021-04-12 date: 2026-04-12 date: 2026-04-12 date: 2024-03-19 date: 2024-03-19 name: IRCCS Eugenio Medea class: OTHER briefSummary: Gait pattern difficulties, balance and coordination deficits often characterize patients with congenital and acquired neuromotor disorders and have a significant impact on the quality of life of these subjects. There are various treatments used and in recent years, the advent of advanced technologies in rehabilitation and, in particular, devices based on virtual reality, has opened up new possibilities in rehabilitation. Virtual reality is a promising strategy that incorporates many principles crucial to motor learning, such as high-intensity, repetitive, goal-oriented tasks, enhanced synchronized sensory signals, and active participation. The virtual environment is also suitable for personalized treatment based on the needs of the individual patient.